Modulation of Arthritis through overexpression of soluble inter-leukin-1 receptor accessory protein (sIL-1RAcP): a novel inhibitor of interleukin-1, distinct from IL-1Ra

Autor: David T. Curiel, L. A. B. Joosten, M. U. Martin, F.A.J. van de Loo, Ruben L. Smeets, Miranda B. Bennink, W.B. van den Berg, Onno J. Arntz

Publikováno v: ResearcherID

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d42e0516c4922a406bca5c746d0c97e3
https://doi.org/10.1007/bf03354221

A Multivalent DNA Nanoparticle/Peptide Hybrid Molecular Modality for the Modulation of Protein–Protein Interactions in the Tumor Microenvironment.

Autor: Roman, Jessica A.¹ (AUTHOR) jroman4@gmu.edu, Girgis, Michael Y.² (AUTHOR), Prisby, Rocìo S.¹ (AUTHOR), Araujo, Robyn P.³ (AUTHOR), Russo, Paul¹ (AUTHOR), Oktay, Esra² (AUTHOR), Luchini, Alessandra¹ (AUTHOR), Liotta, Lance A.¹ (AUTHOR), Veneziano, Remi² (AUTHOR) rvenezia@gmu.edu, Haymond, Amanda¹ (AUTHOR) ahaymond@gmu.edu

Publikováno v: Advanced Nanobiomed Research. Jul2024, Vol. 4 Issue 7, p1-11. 11p.

Soluble interleukin‐1 receptor accessory protein ameliorates collagen‐induced arthritis by a different mode of action from that of interleukin‐1 receptor antagonist.

Autor: R. L. Smeets, L. A. B. Joosten, O. J. Arntz, M. B. Bennink, N. Takahashi, H. Carlsen, M. U. Martin, W. B. van den Berg, F. A. J. van de Loo

Publikováno v: Arthritis & Rheumatism; Jul2005, Vol. 52 Issue 7, p2202-2211, 10p

5-Fluoro/(trifluoromethoxy)-2-indolinone derivatives with anti-interleukin-1 activity.

Autor: Soylu-Eter Ö; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.; Department of Pharmaceutical Chemistry, Institute of Health Sciences, Istanbul University, Istanbul, Turkey., Sevinçli ZŞ; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Van Yüzüncü Yıl University, Van, Turkey., Ersoy B; Department of Cellular and Molecular Medicine, Graduate School of Health Sciences, Koç University, Istanbul, Turkey.; Research Centre for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey., Hasanusta B; Research Centre for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey.; Department of Neuroscience, Graduate School of Health Sciences, Koç University, Istanbul, Turkey., Gatfar U; Department of Molecular Biology and Genetics, Graduate School of Sciences, Koç University, Istanbul, Turkey., Lack NA; Research Centre for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey.; Department of Medical Pharmacology, School of Medicine, Koç University, Istanbul, Turkey.; Department of Urologic Science, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada., Erman B; Department of Chemical and Biological Engineering, College of Engineering, Koç University, Istanbul, Turkey., Gül A; Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey., Orer HS; Research Centre for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey.; Department of Medical Pharmacology, School of Medicine, Koç University, Istanbul, Turkey., Karalı N; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.

Publikováno v: Archiv der Pharmazie [Arch Pharm (Weinheim)] 2023 Dec; Vol. 356 (12), pp. e2300217. Date of Electronic Publication: 2023 Oct 10.

Ahead of her time: The multidimensional impact of Marie Ussing Nylen.

Autor: Robey PG; Skeletal Biology Section, National Institute of Dental and Craniofacial Research, Bethesda, Maryland, USA., Baum BJ; Scientist Emeritus, National Institute of Dental and Craniofacial Research, Bethesda, Maryland, USA.

Publikováno v: Oral diseases [Oral Dis] 2023 Mar; Vol. 29 Suppl 1, pp. 870-877. Date of Electronic Publication: 2022 Oct 11.